2.68
price down icon7.59%   -0.22
 
loading
Schlusskurs vom Vortag:
$2.90
Offen:
$2.85
24-Stunden-Volumen:
158.91K
Relative Volume:
0.68
Marktkapitalisierung:
$3.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.35M
KGV:
-1.8483
EPS:
-1.45
Netto-Cashflow:
$-36.91M
1W Leistung:
+10.74%
1M Leistung:
-21.64%
6M Leistung:
-63.09%
1J Leistung:
-84.79%
1-Tages-Spanne:
Value
$2.59
$2.90
1-Wochen-Bereich:
Value
$2.50
$3.2248
52-Wochen-Spanne:
Value
$2.01
$18.50

Galecto Inc Stock (GLTO) Company Profile

Name
Firmenname
Galecto Inc
Name
Telefon
45-70-70-52-10
Name
Adresse
75 STATE STREET, BOSTON
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
GLTO's Discussions on Twitter

Vergleichen Sie GLTO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GLTO
Galecto Inc
2.68 3.20M 0 -38.35M -36.91M -1.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Galecto Inc Stock (GLTO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-04-26 Fortgesetzt Credit Suisse Outperform
2020-11-23 Eingeleitet BofA Securities Buy
2020-11-23 Eingeleitet Credit Suisse Outperform
2020-11-23 Eingeleitet SVB Leerink Outperform

Galecto Inc Aktie (GLTO) Neueste Nachrichten

pulisher
Apr 16, 2025

Keppel DC REIT (OTCMKTS:KPDCF) Short Interest Up 133.4% in March - Defense World

Apr 16, 2025
pulisher
Apr 16, 2025

Galecto, Inc. (NASDAQ:GLTO) Short Interest Up 133.6% in March - Defense World

Apr 16, 2025
pulisher
Apr 11, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - benzinga.com

Apr 11, 2025
pulisher
Apr 03, 2025

Galecto, Inc. Focuses on Oncology and Liver Diseases - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

GLTO stock touches 52-week low at $2.78 amid sharp annual decline - Investing.com UK

Apr 03, 2025
pulisher
Mar 27, 2025

Galecto stock hits 52-week low at $3.75 amid market challenges - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Galecto stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 26, 2025

Galecto stock hits 52-week low at $4.39 amid market challenges - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews

Mar 26, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Galecto (GLTO) Shares Rally Amid Positive Market Momentum - Stocks Telegraph

Mar 21, 2025
pulisher
Mar 20, 2025

Galecto Reports Full-Year 2024 Financial Results - The Manila Times

Mar 20, 2025
pulisher
Mar 19, 2025

Galecto Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Galecto, Inc. Completes Strategic Review, Acquires Global Rights to GB3226 for Oncology and Liver Disease Focus - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Galecto Cuts Losses by $17M, Acquires Promising AML Drug Candidate - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

Galecto Inc expected to post a loss of $2.97 a shareEarnings Preview - TradingView

Mar 19, 2025
pulisher
Mar 14, 2025

Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approvals, Therapies, Mechanism of Action, Route of Administration & Companies by DelveInsight - The Globe and Mail

Mar 14, 2025
pulisher
Mar 12, 2025

Galecto stock plunges to 52-week low at $3.76 amid market challenges - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

Galecto stock plunges to 52-week low at $3.76 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 07, 2025

Galecto (GLTO) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga

Mar 06, 2025
pulisher
Feb 28, 2025

Galecto stock hits 52-week low at $4.20 amid market challenges - Investing.com Australia

Feb 28, 2025
pulisher
Feb 27, 2025

Galecto stock hits 52-week low at $4.20 amid market challenges By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 15, 2025

Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World

Feb 15, 2025
pulisher
Feb 12, 2025

Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World

Feb 12, 2025
pulisher
Feb 11, 2025

Galecto to Participate in Upcoming Investor Conferences - The Globe and Mail

Feb 11, 2025
pulisher
Feb 11, 2025

Galecto stock hits 52-week low at $4.39 amid market challenges By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 11, 2025

Leerink Partnrs Estimates Galecto FY2024 Earnings - Defense World

Feb 11, 2025
pulisher
Feb 08, 2025

Brokers Set Expectations for Galecto FY2029 Earnings - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

Galecto to Participate in Upcoming Investor Conferences -February 06, 2025 at 08:01 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Biotech Spotlight: Galecto Lines Up Triple Conference Showcase for Investors - StockTitan

Feb 06, 2025
pulisher
Feb 01, 2025

Where are the Opportunities in (GLTO) - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 24, 2025

Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga

Jan 24, 2025
pulisher
Jan 23, 2025

Critical Analysis: Galecto (NASDAQ:GLTO) vs. ObsEva (NASDAQ:OBSV) - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

(GLTO) On The My Stocks Page - Stock Traders Daily

Jan 22, 2025
pulisher
Jan 13, 2025

Analyzing Galecto (NASDAQ:GLTO) and Pasithea Therapeutics (NASDAQ:KTTA) - Defense World

Jan 13, 2025
pulisher
Jan 09, 2025

After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win - PharmaVoice

Jan 09, 2025
pulisher
Jan 07, 2025

Galecto CEO Hans T. Schambye sells $7,509 in shares - Investing.com

Jan 07, 2025

Finanzdaten der Galecto Inc-Aktie (GLTO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Kapitalisierung:     |  Volumen (24h):